
### [MONDO:0016756](http://purl.obolibrary.org/obo/MONDO_0016756)
**Label:** inherited nervous system cancer-predisposing syndrome

**Subclasses:** [MONDO:0018875](http://purl.obolibrary.org/obo/MONDO_0018875) (Li-Fraumeni syndrome), [MONDO:0018975](http://purl.obolibrary.org/obo/MONDO_0018975) (neurofibromatosis), [MONDO:0008075](http://purl.obolibrary.org/obo/MONDO_0008075) (neurofibromatosis type 3), [MONDO:0008077](http://purl.obolibrary.org/obo/MONDO_0008077) (neurofibromatosis, type 1), [MONDO:0019188](http://purl.obolibrary.org/obo/MONDO_0019188) (Rubinstein-Taybi syndrome), [MONDO:0011457](http://purl.obolibrary.org/obo/MONDO_0011457) (ataxia-telangiectasia-like disorder), [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), [MONDO:0019341](http://purl.obolibrary.org/obo/MONDO_0019341) (tuberous sclerosis complex), [MONDO:0013357](http://purl.obolibrary.org/obo/MONDO_0013357) (chromosome 17q11.2 deletion syndrome, 1.4Mb), 

**Corr. equiv. classes:** [Orphanet:100](http://www.orpha.net/ORDO/Orphanet_100), [OMIM:162200](http://purl.obolibrary.org/obo/OMIM_162200), [Orphanet:783](http://www.orpha.net/ORDO/Orphanet_783), [OMIM:162091](http://purl.obolibrary.org/obo/OMIM_162091), [Orphanet:93921](http://www.orpha.net/ORDO/Orphanet_93921), [Orphanet:251347](http://www.orpha.net/ORDO/Orphanet_251347), [Orphanet:805](http://www.orpha.net/ORDO/Orphanet_805), [OMIM:613675](http://purl.obolibrary.org/obo/OMIM_613675), [OMIM:208900](http://purl.obolibrary.org/obo/OMIM_208900), [Orphanet:636](http://www.orpha.net/ORDO/Orphanet_636), [Orphanet:97685](http://www.orpha.net/ORDO/Orphanet_97685), [OMIM:604391](http://purl.obolibrary.org/obo/OMIM_604391), [Orphanet:524](http://www.orpha.net/ORDO/Orphanet_524), 

**Class expressions from DL-Learner:**

- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 65.38%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) 65.38%


